Looking to sell Metronome stock or options?
Metronome offers metering and data mediation software tailored to facilitate metered billing. Its platform provides the necessary data infrastructure, billing logic, and real-time framework essential for usage-based billing, allowing for adaptable integration patterns. This helps software companies to efficiently launch, refine, and expand their usage-based business models.
New Enterprise Associates, Caffeinated Capital, Avichal Garg, General Catalyst, Allison Pickens Ventures, Zachary Perret, Ion Stoica, Elad Gil, William Hockey, Octave (San Francisco), Andreessen Horowitz, ASDF Ventures, Reynold Xin, Christian Kleinerman, Mango Capital (Venture Capital), Lachy Groom, Nathaniel Turner, Cristina Cordova, Armon Dadgar, Neha Narkhede.
Metronome is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Metronome stock. Depending on Metronome’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Metronome stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Metronome stock in two ways. First, Metronome employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Metronome stock. Note that all transactions in Metronome shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Metronome stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Metronome stock. Typically, shares of private companies like Metronome are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jan 2024, Metronome is reported to have closed an equity financing in which the investors valued the company at $346M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Metronome shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Metronome is not currently publicly traded, it does not have a ticker symbol.
Metronome has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Metronome is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Metronome shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.